Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
Sean Ekins(Collaborative Drug Discovery (United States)), Kenneth Bachmann(University of Toledo), Manisha Iyer(University of Pittsburgh), Peter W. Swaan(University of Maryland, Baltimore), Matthew D. Krasowski(University of Iowa), Sridhar Mani(Albert Einstein College of Medicine), Vladyslav Kholodovych(Rutgers, The State University of New Jersey), Rachana Patel(University of Toledo), Michael Sinz(Rutgers, The State University of New Jersey), Cheng Chang(National University of Singapore), Ni Ai(Memorial Sloan Kettering Cancer Center), William J. Welsh(University of Iowa), Erica J. Reschly(University of Pittsburgh)
Cited by 146
Related Papers
Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose–response framework
|Toxicology and Applied Pharmacology|2007|755
<i>In silico</i> pharmacology for drug discovery: methods for virtual ligand screening and profiling
|British Journal of Pharmacology|2007|693
Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information
|Journal of Computer-Aided Molecular Design|2011|686
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312